Categories: News

(CORRECTION) XcelPlus International 1-to-100 reverse stock split

Reno, Nevada, July 23, 2021 (GLOBE NEWSWIRE) — XcelPlus International Inc. (OTC Pink: XLPI) today announced a 1-for-100 reverse split of its outstanding common stock. The effective date of the stock split is July 26, 2021.

While the Financial Industry Regulatory Authority (FINRA) did process the reverse split, FINRA has neither approved nor disapproved the action. FINRA’s processing of the reverse split does not constitute FINRA approval. Furthermore, FINRA’s processing of the reverse split does not mean that FINRA has considered the company’s compliance with any federal, state, or other self-regulatory requirements.

“I ask our shareholders to be patient as we complete this transition” said XLPI President and CEO, Mr. Charles Robinson.  “There are many wheels turning here at XcelPlus. We are working diligently to provide value and transparency to our shareholders, and to that end, we expect to be posting our un-audited financial statements and other important information on our website in the coming weeks.

Forward Looking Statements
Certain statements in this communication constitute “forward-looking statements” under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements of future expectations and events, future strategic objectives, business prospects and anticipated results. Forward looking statements can often be identified by words such as  “will,” “can,” “moving,” “expect,” and similar expressions and include, but are not limited to, statements regarding or relating to the company’s capital structure and acquisition strategies, the company’s initiatives, the company’s transition into any industry, our ability to bring products, services and technologies to market and the ultimate success in the marketplace of such products, services and technologies. Forward-looking statements are not guarantees of future results and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially and adversely from those expressed or implied in such statements. These statements are based on management’s current views and assumptions, speak only as of the date hereof and are subject to change. We undertake no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Contact: Ian Douglass
Chief Communications Officer
info@xcelplusint.com
346-348-4034

Staff

Recent Posts

Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board

BERLIN, GERMANY / ACCESSWIRE / April 3, 2024 / Berlin Cures, a biotechnology company in…

3 hours ago

Mars Veterinary Health pilots industry-leading anaesthetic gas capture technology to reduce carbon emissions

World's leading provider of veterinary care will be first to introduce innovative in-clinic solution to…

6 hours ago

Gesund.ai Named to the 2024 CB Insights AI 100 List

Gesund.ai recognized for achievements in bringing healthcare AI from the lab to the clinic at…

6 hours ago

StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results

TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero"…

6 hours ago

CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for…

12 hours ago

Oklahoma Proton Center Celebrates Milestone Achievement: 5,000th Patient Successfully Treated

OKLAHOMA CITY, April 2, 2024 /PRNewswire/ -- In a momentous occasion, Oklahoma Proton Center, a…

12 hours ago